Finance

Beta
Lists
CLCS:OTCMKTS
Cell Source Inc
$0.82
+6.49%
(+0.050) 1D
Jun 12, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLCS...
Open
$0.80
High
$0.82
Low
$0.80
Mkt. cap
55.72M
Avg. vol.
1.83K
Volume
250.00
52-wk high
$2.25
52-wk low
$0.23
Beta
0.34
Shares outstanding
67.95M
No. of employees
1
Open
$0.80
High
$0.82
Low
$0.80
Mkt. cap
55.72M
Avg. vol.
1.83K
Volume
250.00
52-wk high
$2.25
52-wk low
$0.23
Beta
0.34
Shares outstanding
67.95M
No. of employees
1
News stories
From sources across the web
About Cell Source Inc
CEO-
Employees1
Founded2012
Headquarters-
SectorBiotechnology
Websitecell-source.com
Previous reports
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2024
Sep 2024
Mar 2025
Revenue
-
-
-
Cost of goods sold
-
-
-
Cost of revenue
-
-
-
Research and development expenses
820.01K
360.86K
515.18K
Total research and development expenses
-
-
-
Selling, general, and admin expenses
373.67K
470.77K
483.40K
Operating expense
1.19M
831.62K
998.59K
Total operating expenses
1.19M
831.62K
998.59K
Operating income
-1.19M
-831.62K
-998.59K
Other non operating income
11.15K
-98.55K
30.61K
EBT including unusual items
-1.49M
-1.42M
-1.48M
EBT excluding unusual items
-1.49M
-1.44M
-1.48M
Income tax expense
-
-
-
Effective tax rate
-
-
-
Other operating expenses
-
-
-
Net income
-1.49M
-1.42M
-1.48M
Net profit margin
-
-
-
Earnings per share
-
-
-
Interest and investment income
-
-
-
Interest expense
-306.26K
-504.86K
-513.87K
Net interest expenses
-306.26K
-504.86K
-513.87K
Depreciation and amortization charges
-
-
-
EBITDA
-
-
-
Gain or loss from assets sale
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer